Viewing Study NCT02255461


Ignite Creation Date: 2025-12-24 @ 12:39 PM
Ignite Modification Date: 2026-01-25 @ 4:19 AM
Study NCT ID: NCT02255461
Status: TERMINATED
Last Update Posted: 2021-03-02
First Post: 2014-09-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Sponsor: Pediatric Brain Tumor Consortium
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: PBTC-042
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View